MENU
IOVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iovance Biotherapeutics (IOVA) Ownership - Who owns Iovance Biotherapeutics?

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
975
Web
https://www.iovance.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.54B
P/E Ratio
N/A
Total Cash
313.44M
Projected Growth
N/A
Total Debt
47.78M
Revenue
285.61M
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
0.70
Total Debt/Equity
N/A
Revenue/Share
0.75 USD as % of share price
View a ticker or compare two or three
IOVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biotechnological products for the treatment of cancer

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
975
Web
https://www.iovance.com